Hemoglobin is a protein inside red blood cells that helps carry oxygen from the lungs to the rest of the body. Glucose (sugar) in the blood slowly attaches to hemoglobin to form hemoglobin A 1c (HbA 1c ). The more glucose in the blood, the more HbA 1c is formed. As a result, the percentage of hemoglobin that is HbA 1c reflects the average value for blood sugar during the previous 2 to 3 months. The American Diabetes Association encourages people to use the percentage of HbA 1c to keep track of how well their diabetes is being controlled, and until recently doctors would tell people to aim for a target of 7%. But, when everyone has the same target, some people have blood sugar values that are too high and others have values that are too low. As a result, many doctors now increase or decrease the target according to the person's age, medical history, and remaining years of life and how likely they are to have very low blood sugar, which is especially dangerous.
What is the problem and what is known about it so far?
Hemoglobin is a protein inside red blood cells that helps carry oxygen from the lungs to the rest of the body. Glucose (sugar) in the blood slowly attaches to hemoglobin to form hemoglobin A 1c (HbA 1c ). The more glucose in the blood, the more HbA 1c is formed. As a result, the percentage of hemoglobin that is HbA 1c reflects the average value for blood sugar during the previous 2 to 3 months. The American Diabetes Association encourages people to use the percentage of HbA 1c to keep track of how well their diabetes is being controlled, and until recently doctors would tell people to aim for a target of 7%. But, when everyone has the same target, some people have blood sugar values that are too high and others have values that are too low. As a result, many doctors now increase or decrease the target according to the person's age, medical history, and remaining years of life and how likely they are to have very low blood sugar, which is especially dangerous.
Why did the researchers do this particular study?
No one knows how much it costs to use different HbA 1c targets for different people instead of using the same target for everyone.
Who was studied?
People with type 2 diabetes who represented all such people in the United States.
How was the study done?
The researchers created a computer model that combined existing information about the frequency of problems with existing information about how much it costs to treat those problems. The researchers then used the model to predict what problems people might have in the future, how long they would live, and how much it would cost to provide their care.
What did the researchers find?
Using different targets for different people led to fewer medications, less expensive care, and a slightly shorter length of life but a slightly higher quality of life.
What were the limitations of the study?
Younger people who don't mind taking a lot of medications might be better off with an HbA 1c target of 7%.
What are the implications of the study?
If individualized HbA 1c targets are used more often, people will take fewer medications and will have less expensive care and better quality of life. 
